Article Details
Retrieved on: 2024-05-14 19:52:42
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
On Tuesday, Goldman Sachs reiterated a Neutral rating for Dynavax (NASDAQ:DVAX) Technologies (NASDAQ:DVAX), maintaining a price target of $20.00.
Article found on: www.investing.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here